Disease Markers · 2015 · 19 citations · 20 references
Life SciencesClinical SciencesImmunologyAutoimmunityImmunopathologyInflammationAutoimmune BiomarkersAutoimmune Disease DiagnosticsAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune InflammationInflammatory BiomarkersActive Disease DifferentiationBiomarkers Of Autoimmune ActivityBiomarkers Of Disease FlareDisease Activity MeasurementMatched Control GroupSystemic Inflammation MarkersSystemic Inflammatory Response Syndrome CriteriaTotal Serum Bilirubin
PURPOSE: To compare the laboratory data and changes in these data between patients with MAS and patients with flare-up of the autoimmune diseases. METHODS: In a prospective study, the static laboratory data and dynamic changes in the selected data in 17 consecutive patients with MAS and 53 patients with active disease of SJIA, PJIA, Kawasaki disease, and SLE were compared. The ROC curve analysis was used to evaluate cut-off points, sensitivity, and specificity of the static and dynamic laboratory data to differentiate between MAS and active disease. RESULTS: In the MAS group, the mean CRP3, ALT, AST, total bilirubin, ferritin, LDH, PT, PTT, and INR were significantly higher and the mean WBC2, PMN2, Lymph2, Hgb1, 2, 3, ESR2, serum albumin, and sodium were significantly lower than in control group. Some of the important cut-off points were PLT2 < 209000/microliter, AST > 38.5, ALT > 38, WBC < 8200 × 103/UL, ferritin > 5277 ng/mL. CONCLUSION: The dynamic changes in some laboratory data, especially PLT, can differentiate between MAS and active disease. The changes in WBC, PMN, and ESR and the levels of the liver enzymes may also be helpful in the early differentiation. Very high levels of ferritin may also help the diagnosis along with other clinical and laboratory signs.
20
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan‐Inge Henter, AnnaCarin Horne, Maurizio Aricò et al. · Pediatric Blood & Cancer · 2006 · 5.3K citations
Medicine, Hematology, Immunology +17
C-reactive protein: a critical update
Mark B. Pepys, Gideon M. Hirschfield · Journal of Clinical Investigation · 2003 · 3.4K citations · Full text
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Jane W. Newburger, Masato Takahashi, Michael A. Gerber et al. · Circulation · 2004 · 1.9K citations · Full text